Neuroleptics Do Much More Harm Than Good and Should Not Be Used

• Belmaker, R. H., & Wald, D. (1977). Haloperidol in normals. The British Journal of Psychiatry, 131, 222–223.

  Article  PubMed  Google Scholar 

• Bola, J., Kao, D., & Soydan, H. (2011). Antipsychotic medication for early episode schizophrenia. Cochrane Database of Systematic Reviews, 6, CD006374.

  Google Scholar 

• Breggin, P. R. (2006). Intoxication anosognosia: The spellbinding effect of psychiatric drugs. Ethical Human Psychology and Psychiatry, 8, 201–215.

  Article  Google Scholar 

• Breggin, P. R. (2008). Brain-disabling treatments in psychiatry: Drugs, electroshock, and the psychopharmaceutical complex. Springer.

  Google Scholar 

• Breggin, P. (2012). Psychiatric drug withdrawal: A guide for prescribers, therapists, patients and their families. Springer.

  Book  Google Scholar 

• Chen, E. Y., Hui, C. L., Lam, M. M., Chiu, C. P., Law, C. W., Chung, D. W., et al. (2010). Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: Randomised controlled trial. The BMJ, 341, c4024.

  Article  PubMed Central  PubMed  Google Scholar 

• Cole, J. O. (1964). Phenothiazine treatment in acute schizophrenia; effectiveness: The National Institute of Mental Health Psychopharmacology Service Center Collaborative Study Group. Archives of General Psychiatry, 10, 246–261.

  Google Scholar 

• Danborg, P. B., & Gøtzsche, P. C. (2019). Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review. International Journal of Risk & Safety in Medicine, 30, 193–201. Free access.

  Article  Google Scholar 

• Dold, M., Li, C., Tardy, M., Khorsand, V., Gillies, D., & Leucht, S. (2012). Benzodiazepines for schizophrenia. Cochrane Database of Systematic Reviews, 11, CD006391.

  PubMed  Google Scholar 

• FDA package insert for risperidone (Risperdal). https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020272s056,020588s044,021346s033,021444s03lbl.pdf. Accessed 30 May 2022.

• Fiorillo, A., De Rosa, C., Del Vecchio, V., Jurjanz, L., Schnall, K., Onchev, G., et al. (2011). How to improve clinical practice on involuntary hospital admissions of psychiatric patients: Suggestions from the EUNOMIA study. European Psychiatry, 26, 201–207.

  Article  PubMed  Google Scholar 

• Francey, S. M., O’Donoghue, B., Nelson, B., Graham, J., Baldwin, L., Yuen, H. P., et al. (2020). Psychosocial intervention with or without antipsychotic medication for first episode psychosis: A randomized noninferiority clinical trial. Schizophrenia Bulletin Open. https://doi.org/10.1093/schizbullopen/sgaa015

• Gottstein, J. (2020). The Zyprexa papers. Jim Gottstein.

  Google Scholar 

• Gøtzsche, P. C. (2013). Deadly medicines and organised crime: How big pharma has corrupted health care. London: Radcliffe Publishing.

  Google Scholar 

• Gøtzsche, P. C. (2015). Deadly psychiatry and organised denial. People’s Press.

  Google Scholar 

• Gøtzsche, P. C. (2019). Forced drugging with antipsychotics is against the law: Decision in Norway. Mad in America (May 4). https://www.madinamerica.com/2019/05/forced-drugging-antipsychotics-against-law/

• Gøtzsche, P. C. (2022a). Mental health survival kit and withdrawal from psychiatric drugs. L H Press.

  Google Scholar 

• Gøtzsche, P. C. (2022b). Critical psychiatry textbook. Institute for Scientific Freedom.

  Google Scholar 

• Gøtzsche, P. C., & Sørensen, A. (2020). Systematic violations of patients’ rights and lack of safety: Cohort of 30 patients forced to receive antipsychotics. Indian Journal of Medical Ethics, 5(4), 312–318. Free access.

  Article  Google Scholar 

• Gøtzsche, P. C., Vinther, S., & Sørensen, A. (2019). Forced medication in psychiatry: Patients’ rights and the law not respected by Appeals Board in Denmark. Clinical Neuropsychiatry, 16, 229–233. Free access.

  PubMed Central  PubMed  Google Scholar 

• Hegelstad, W. T., Larsen, T. K., Auestad, B., Evensen, J., Haahr, U., Joa, I., et al. (2012). Long-term follow-up of the TIPS early detection in psychosis study: Effects on 10-year outcome. The American Journal of Psychiatry, 169, 374–380.

  Article  PubMed  Google Scholar 

• Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017). Years of potential life lost and life expectancy in schizophrenia: A systematic review and meta-analysis. Lancet Psychiatry, 4, 295–301.

  Article  PubMed  Google Scholar 

• Ho, B. C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011). Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Archives of General Psychiatry, 68, 128–137.

  Article  PubMed Central  PubMed  Google Scholar 

• Hróbjartsson, A., Thomsen, A. S., Emanuelsson, F., Tendal, B., Hilden, J., Boutron, I., et al. (2013). Observer bias in randomized clinical trials with measurement scale outcomes: A systematic review of trials with both blinded and nonblinded assessors. CMAJ, 185, E201–E211.

  Article  PubMed Central  PubMed  Google Scholar 

• Hughes, S., Cohen, D., & Jaggi, R. (2014). Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: A cross-sectional study. BMJ Open, 4, e005535.

  Article  PubMed Central  PubMed  Google Scholar 

• Hui, C. L. M., Honer, W. G., Lee, E. H. M., Chang, W. C., Chan, S. K. W., Chen, E. S. M., et al. (2018). Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: A 10 year follow-up of a randomised, double-blind trial. Lancet Psychiatry, 5, 432–442.

  Article  PubMed  Google Scholar 

• Karon, B. P. (2009). All I know about Peter Breggin. In C. B. Pert et al. (Eds.), The Conscience of Psychiatry. The reform work of Peter R. Breggin, MD. Lake Edge Press.

  Google Scholar 

• Khin, N. A., Chen, Y. F., Yang, Y., Yang, P., & Laughren, T. P. (2012). Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration. The Journal of Clinical Psychiatry, 73, 856–864.

  Article  PubMed  Google Scholar 

• Koponen, M., Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. M., et al. (2017). Risk of mortality associated with antipsychotic monotherapy and polypharmacy among community-dwelling persons with Alzheimer’s disease. Journal of Alzheimer’s Disease, 56, 107–118.

  Article  PubMed  Google Scholar 

• Krupnick, J. L., Sotsky, S. M., Simmens, S., Moyer, J., Elkin, I., Watkins, J., et al. (1996). The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology, 64, 532–539.

  Article  PubMed  Google Scholar 

• Leucht, S., Kane, J. M., Etschel, E., Kissling, W., Hamann, J., & Engel, R. R. (2006). Linking the PANSS, BPRS, and CGI: Clinical implications. Neuropsychopharmacology, 31, 2318–2325.

  Article  PubMed  Google Scholar 

• Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., et al. (2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. Lancet, 379, 2063–2071.

  Article  PubMed  Google Scholar 

• Melle, I., Olav Johannesen, J., Haahr, U. H., Ten Velden, H. W., Joa, I., Langeveld, J., et al. (2017). Causes and predictors of premature death in first-episode schizophrenia spectrum disorders. World Psychiatry, 16, 217–218.

  Article  PubMed Central  PubMed  Google Scholar 

• Moncrieff, J. (2013). The bitterest pills. Palgrave Macmillan.

  Book  Google Scholar 

• Moncrieff, J. (2015). Antipsychotic maintenance treatment: Time to rethink? PLoS Medicine, 12, e1001861.

  Article  PubMed Central  PubMed  Google Scholar 

• Moncrieff, J., & Cohen, D. (2006). Do antidepressants cure or create abnormal brain states? PLoS Medicine, 3, e240.

  Article  PubMed Central  PubMed  Google Scholar 

• Moncrieff, J., Wessely, S., & Hardy, R. (2004). Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews, 1, CD003012.

  Google Scholar 

• Morrison, A. P., Turkington, D., Pyle, M., et al. (2014). Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: A single-blind randomised controlled trial. Lancet, 383, 1395–1403.

  Article  PubMed  Google Scholar 

• Nilsonne, Å. (2017). Processen: möten, mediciner, beslut. Stockholm.

  Google Scholar 

• Scanlan, J. N. (2010). Interventions to reduce the use of seclusion and restraint in inpatient psychiatric settings: What we know so far, a review of the literature. International Journal of Social Psychiatry, 56, 412–423.

  Article  PubMed  Google Scholar 

• Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943.

  Article  PubMed  Google Scholar 

• Seikkula, J., Aaltonen, J., Alakare, B., Haarakangas, K., Keränen, J., & Lehtinen, K. (2006). Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: Treatment principles, follow-up outcomes, and two case studies. Psychotherapy Research, 16, 214–228.

  Article  Google Scholar 

• Shevlin, M., Houston, J. E., Dorahy, M. J., & Adamson, G. (2008). Cumulative traumas and psychosis: An analysis of the national comorbidity survey and the British Psychiatric Morbidity Survey. Schizophrenia Bulletin, 34, 193–199.

  Article  PubMed  Google Scholar 

• Svedberg, B., Mesterton, A., & Cullberg, J. (2001). First-episode non-affective psychosis in a total urban population: A 5-year follow-up. Social Psychiatry and Psychiatric Epidemiology, 36, 332–337.

  Article  PubMed  Google Scholar 

• Tasch, G., & Gøtzsche, P. C. (2023). Systematic violations of patients’ rights and safety: Forced medication of a cohort of 30 patients in Alaska. Psychosis (in press).

  Google Scholar 

• Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., et al. (2012). Childhood adversities increase the risk of psychosis: A meta-analysis of patientcontrol, prospective- and cross-sectional cohort studies. Schizophrenia Bulletin, 38, 661–671.

  Article  PubMed Central  PubMed  Google Scholar 

• Wang, C. H., Li, Y., Yang, J., Su, L. Y., Geng, Y. G., Li, H., et al. (2013). A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia. Schizophrenia Research, 144, 129–135.

  Article  PubMed  Google Scholar 

• What does akathisia and tardive dyskinesia look like? (Undated). Videos of children and adults who have been permanently brain damaged by neuroleptics. https://www.deadlymedicines.dk/lectures/

• Whitaker, R. (2002). Mad in America: Bad science, bad medicine, and the enduring mistreatment of the mentally ill. Perseus Books Group.

  Google Scholar 

• Whitaker, R. (2015). Anatomy of an epidemic (2nd ed.). Broadway Paperbacks.

  Google Scholar 

• Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: Long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70, 913–920.

  Article  PubMed  Google Scholar 

• Zinkler, M., & von Peter, S. (2019). End coercion in mental health services – Toward a system based on support only. Laws, 8, 19.

  Article  Google Scholar 

Download references